Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DTG, DRV/r and NRTI as Third-line HIV Regimen in Cambodia
NCT03602690Phase 2Unknown
- Sponsor
- ANRS
- Start
- Oct 2018
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of dolutegravir, darunavir and ritonavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Status: unknown.
02
Drugs
dolutegravirdarunavirritonavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03602690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03602690.